About Invengene
Invengene is a company based in Mumbai (India) founded in 2023. It operates as a B2B. Invengene offers products and services including R&D Services, Manufacturing Services, and Commercialization Services. Invengene operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Mumbai, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Invengene Private Limited
- Date of Incorporation 02 Aug, 2023
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
-$515.42 K (USD)0as on Mar 31, 2024
-
EBITDA
-$673.83 K (USD)0as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Invengene
Invengene offers a comprehensive portfolio of products and services, including R&D Services, Manufacturing Services, and Commercialization Services.
Offers ideation and development for pharmaceutical products
Handles scale-up and manufacturing of injectables
Manages regulatory filing and market launch strategies
People of Invengene
Unlock access to complete
Unlock access to complete
Funding Insights of Invengene
Detailed funding history for Invengene
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Invengene
Investment portfolio details for Invengene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Invengene
Detailed financials for Invengene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invengene Comparisons
Peer comparison for Invengene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Invengene
Invengene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| Locked | Locked | Locked |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Detailed competitors of Invengene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invengene
Complete news archive for Invengene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invengene
Invengene was founded in 2023.
Invengene is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Invengene delivers comprehensive pharmaceutical services, including research and development, manufacturing, and business development, focusing on drug delivery technologies like injectables. The company partners with global entities to bridge portfolio gaps in emerging and regulated markets, ensuring efficient scaling and regulatory compliance. Based in India, it supports clients from product ideation to market launch with a skilled team.
Invengene's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Invengene offers R&D Services, Manufacturing Services, and Commercialization Services.